RALLIS CHRIS A 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Jul 8, 2024
Insider Transaction Report
Form 4
RALLIS CHRIS A
Director
Transactions
- Exercise/Conversion
Common Shares
2024-07-05$2.79/sh+1,792$5,000→ 47,630 total - Sale
Common Shares
2024-07-05$6.03/sh−1,173$7,073→ 46,457 total - Exercise/Conversion
Common Shares
2024-07-05$2.79/sh−1,792$5,000→ 179,802 totalExercise: $2.79From: 2014-08-04Exp: 2024-08-04→ Options (1,792 underlying)
Footnotes (3)
- [F1]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- [F2]Shares sold to satisfy tax obligation on option exercise.
- [F3]Represents options exercised pursuant to a 10b5-1 program adopted August 17, 2023.